Nanosphere Health Sciences Inc (NSHS.CX)
0.025
0.00 (0.00%)
CAD |
CNSX |
May 03, 09:46
Nanosphere Health Sciences Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2020 | 0.0459M |
| September 30, 2020 | 0.0232M |
| June 30, 2020 | -0.1158M |
| March 31, 2020 | -0.1014M |
| December 31, 2019 | 1.697M |
| September 30, 2019 | 3.142M |
| June 30, 2019 | 3.361M |
| March 31, 2019 | 3.886M |
| December 31, 2018 | 1.676M |
| September 30, 2018 | 5.541M |
| June 30, 2018 | 5.690M |
| March 31, 2018 | 5.281M |
| December 31, 2017 | 5.777M |
| September 30, 2017 | -0.0531M |
| June 30, 2017 | 1.127M |
| March 31, 2017 | 1.035M |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | 0.4851M |
| December 31, 2014 | 0.4851M |
| Date | Value |
|---|---|
| September 30, 2014 | 0.4909M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | 0.292M |
| June 30, 2012 | -0.3844M |
| March 31, 2012 | 6.855M |
| December 31, 2011 | 11.84M |
| September 30, 2011 | 16.23M |
| June 30, 2011 | 16.90M |
| March 31, 2011 | 9.663M |
| December 31, 2010 | 4.682M |
| September 30, 2010 | 0.0009M |
| June 30, 2010 | 0.0021M |
| March 31, 2010 | -0.0007M |
| December 31, 2009 | 0.0013M |
| September 30, 2009 | -0.0046M |
| June 30, 2009 | -0.0054M |
| March 31, 2009 | -0.003M |
| December 31, 2008 | -0.0019M |
| September 30, 2008 | 0.951M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.1158M
Minimum
Jun 2020
3.361M
Maximum
Jun 2019
1.150M
Average
0.0459M
Median
Dec 2020
Cash from Financing (TTM) Benchmarks
| Biocure Technology Inc | 0.3224M |
| Core One Labs Inc | -- |
| Nova Mentis Life Science Corp | -- |
| Lobe Sciences Ltd | 1.527M |
| Algernon Pharmaceuticals Inc | 2.158M |